ROCKWELL MEDICAL
RMTI Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-07-01
2025-07-03
STROBECK MARK
President and CEO
S - Sale
Common Stock
-6,926
$0.82
-5,679.32
1
$38.62M
2025-07-01
2025-07-02
STROBECK MARK
President and CEO
S - Sale
Common Stock
-6,926
$0.82
-5,679.32
1
$38.62M
2025-05-20
2025-05-21
CHOLE TIMOTHY
SVP, Chief Commercial Officer
A - Grant
Common Stock
85,000
$0.00
1
$38.62M
2025-05-20
2025-05-21
NERI JESSE
SVP, FINANCE AND CFO
A - Grant
Stock Option (Right to Buy)
195K
$0.00
1
$38.62M
2025-05-20
2025-05-21
CHOLE TIMOTHY
SVP, Chief Commercial Officer
A - Grant
Stock Option (Right to Buy)
170K
$0.00
1
$38.62M
2025-05-20
2025-05-21
STROBECK MARK
President and CEO
A - Grant
Stock Option (Right to Buy)
308K
$0.00
1
$38.62M
2025-05-20
2025-05-21
TIMMINS MEGAN
EVP, CLO and Secretary
A - Grant
Stock Option (Right to Buy)
195K
$0.00
1
$38.62M
2025-04-11
2025-04-15
IRREVOCABLE LARSON FAMILY INVESTMENT TRUST
P - Purchase
Common Stock
30,500
$1.00
30,500
13
$38.62M
2025-04-10
2025-04-15
IRREVOCABLE LARSON FAMILY INVESTMENT TRUST
P - Purchase
Common Stock
57,000
$1.00
57,000
17
$38.62M
2025-04-01
2025-04-02
CHOLE TIMOTHY
SVP, Chief Commercial Officer
S - Sale
Common Stock
-2,868
$1.00
-2,868
1
$38.62M
2025-03-17
2025-03-18
CHOLE TIMOTHY
SVP, Chief Commercial Officer
F - Tax
Common Stock
-2,823
$2.00
-5,646
1
$38.62M
2025-03-17
2025-03-18
TIMMINS MEGAN
EVP, CLO and Secretary
F - Tax
Common Stock
-3,137
$2.00
-6,274
1
$38.62M
2025-03-14
2025-03-18
TIMMINS MEGAN
EVP, CLO and Secretary
F - Tax
Common Stock
-3,666
$2.00
-7,332
1
$38.62M
2025-03-14
2025-03-18
CHOLE TIMOTHY
SVP, Chief Commercial Officer
F - Tax
Common Stock
-2,444
$2.00
-4,888
1
$38.62M
2025-01-02
2025-01-06
CHOLE TIMOTHY
SVP, Chief Commercial Officer
S - Sale
Common Stock
-1,001
$2.00
-2,002
1
$38.62M
2024-10-01
2024-10-02
CHOLE TIMOTHY
SVP, Chief Commercial Officer
S - Sale
Common Stock
-1,001
$4.00
-4,004
1
$38.62M
2024-03-17
2024-03-19
TIMMINS MEGAN
EVP, CLO and Secretary
F - Tax
Common Stock
-3,137
$1.00
-3,137
1
$38.62M
2024-03-14
2024-03-15
STROBECK MARK
President and CEO
A - Grant
Stock Option (Right to Buy)
142K
$0.00
1
$38.62M
2024-03-14
2024-03-15
TIMMINS MEGAN
EVP, CLO and Secretary
A - Grant
Stock Option (Right to Buy)
70,780
$0.00
1
$38.62M
2024-03-14
2024-03-15
NERI JESSE
SVP, FINANCE
A - Grant
Stock Option (Right to Buy)
47,190
$0.00
1
$38.62M
2023-10-16
2023-10-18
NERI JESSE
SVP, FINANCE
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$38.62M
2023-03-17
2023-03-21
HOFFMAN MARC
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
32,990
$0.00
1
$38.62M
2023-03-17
2023-03-21
STROBECK MARK
President and CEO
A - Grant
Stock Option (Right to Buy)
77,105
$0.00
1
$38.62M
2023-03-17
2023-03-21
MCGARRY PAUL
SVP, Finance and CAO
A - Grant
Stock Option (Right to Buy)
37,210
$0.00
1
$38.62M
2022-03-17
2023-03-21
TIMMINS MEGAN
EVP, CLO and Secretary
A - Grant
Stock Option (Right to Buy)
37,210
$0.00
1
$38.62M
2022-09-09
2022-09-13
HOFFMAN MARC
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$38.62M
2022-09-09
2022-09-13
MCGARRY PAUL
VP, Finance
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$38.62M
2022-09-09
2022-09-13
SKIBSTED RUSSELL
EVP, Chief Financial Officer a...
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$38.62M
2022-09-09
2022-09-13
TIMMINS MEGAN
SVP, General Counsel
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$38.62M
2022-07-01
2022-07-05
STROBECK MARK
President and CEO
A - Grant
Stock Option (Right to Buy)
400K
$0.00
1
$38.62M
2021-08-16
2021-08-18
TIMMINS MEGAN
SVP, General Counsel and Secre...
A - Grant
Stock Option (Right to Buy)
350K
$0.00
1
$38.62M
2021-06-17
2021-06-22
MCLAUGHLIN JOHN PETER
A - Grant
Stock Option (Right to Buy)
72,857
$0.00
1
$38.62M
2021-05-03
2021-06-03
PRATT RAYMOND DENNIS
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$38.62M
2021-05-03
2021-06-03
HOFFMAN MARC
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$38.62M
2021-05-03
2021-06-03
MCGARRY PAUL
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$38.62M
2021-05-03
2021-06-03
ELLISON RUSSELL
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$38.62M
2020-09-15
2020-09-16
SKIBSTED RUSSELL
EVP, Chief Financial Officer a...
A - Grant
Stock Option (Right to Buy)
750K
$0.00
2
$38.62M
2020-06-11
2020-06-12
MCGARRY PAUL
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$38.62M
2020-05-18
2020-05-20
MCLAUGHLIN JOHN PETER
A - Grant
Stock Option (Right to Buy)
34,024
$0.00
1
$38.62M
2020-05-14
2020-05-14
ELLISON RUSSELL
President and Chief Executive ...
P - Purchase
Common Stock
2,000
$2.00
4,000
1
$38.62M
2020-04-26
2020-04-27
GUPTA AJAY
Sr. VP & Chief Scientific Off.
F - Tax
Common Stock
-1,758
$2.00
-3,516
1
$38.62M
2020-04-26
2020-04-27
PRATT RAYMOND DENNIS
VP of Drug Development
F - Tax
Common Stock
-4,612
$2.00
-9,224
1
$38.62M
2020-04-17
2020-04-20
ELLISON RUSSELL
President and Chief Executive ...
A - Grant
Stock Option (Right to Buy)
1.20M
$0.00
2
$38.62M